FDA inspection
LCC Ltd.: FDA inspection ending Mar 22, 2024
FDA inspection 1234178 · Official Action Indicated (OAI) · Eumseong
Key facts
| Inspection ID | 1234178 |
|---|---|
| Firm | LCC Ltd. |
| FEI number | 3007255059 |
| Address | 738-13 Samyang-Ro, Daeso-Myeon |
| City | Eumseong |
| Country | Korea (the Republic of) |
| Fiscal year | 2024 |
| Inspection end date | Mar 22, 2024 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 688576 |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data